INFLIXIMAB THERAPY AND THE CENTRAL NERVOUS DEMYELINATION IN PATIENTS WITH KAWASAKI DISEASE

被引：1

作者：

Sagara, Yuka ^{[1
]}

Muneuchi, Jun ^{[1
]}

Shimabukuro, Wataru ^{[1
]}

Joo, Masahiko ^{[1
]}

Yoshino, Miwa ^{[1
]}

Nakamura, Ryoko ^{[1
]}

Yoneda, Toru ^{[1
]}

Sugitani, Yuichiro ^{[1
]}

Watanabe, Mamie ^{[1
]}

Mizushima, Akira ^{[2
]}

Takahashi, Yasuhiko ^{[1
]}

机构：

[1] Japan Commun Healthcare Org Kyushu Hosp, Dept Pediat, Kitakyushu, Fukuoka, Japan

[2] Japan Commun Healthcare Org Kyushu Hosp, Dept Radiol, Kitakyushu, Fukuoka, Japan

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2019年 / 38卷 / 08期

关键词：

Kawasaki disease; infliximab; intravenous immunoglobulin; complication; central nervous system; ALPHA THERAPY; PREDICTION;

D O I：

10.1097/INF.0000000000002296

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We performed brain magnetic resonance imaging in 14 patients with Kawasaki disease who were treated with infliximab (IFX) at 56 months of age (32-62 months of age) and 23 months (5-35 months) after IFX therapy. Magnetic resonance imaging showed no finding of the central nervous demyelination. IFX therapy is not related to central nervous demyelination in patients with Kawasaki disease.

引用

页码：E185 / E187

页数：4

共 9 条

[1] Infliximab Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease
Burns, Jane C.
Best, Brookie M.
Mejias, Asuncion
Mahony, Lynn
Fixler, David E.
Jafri, Hasan S.
Melish, Marian E.
Jackson, Mary Anne
Asmar, Basim I.
Lang, David J.
Connor, James D.
Capparelli, Edmund V.
Keen, Monica L.
Mamun, Khalid
Keenan, Gregory F.
Ramilo, Octavio
[J]. JOURNAL OF PEDIATRICS, 2008, 153 (06) : 833 - 838
[2] Infliximab treatment for refractory Kawasaki syndrome
Burns, JC
Mason, WH
Hauger, SB
Janai, H
Bastian, JF
Wohrley, JD
Balfour, I
Shen, CA
Michel, ED
Shulman, ST
Melish, ME
[J]. JOURNAL OF PEDIATRICS, 2005, 146 (05) : 662 - 667
[3] Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
Egami, Kimiyasu
Muta, Hiromi
Ishii, Masahiro
Suda, Kenji
Sugahara, Yoko
Iemura, Motofumi
Matsuishi, Toyojiro
[J]. JOURNAL OF PEDIATRICS, 2006, 149 (02) : 237 - 240
[4] Demyelination and other neurological adverse events after anti-TNF therapy
Kaltsonoudis, Evripidis
Voulgari, Paraskevi V.
Konitsiotis, Spyridon
Drosos, Alexandros A.
[J]. AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 54 - 58
[5] Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease
Kobayashi, Tohru
Inoue, Yoshinari
Takeuchi, Kazuo
Okada, Yasunori
Tamura, Kazushi
Tomomasa, Takeshi
Kobayashi, Tomio
Morikawa, Akihiro
[J]. CIRCULATION, 2006, 113 (22) : 2606 - 2612
[6] Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO
[7] 2-W
[8] Magnetic resonance studies of brain lesions in patients with Kawasaki disease
Muneuchi, J
Kusuhara, K
Kanaya, Y
Ohno, T
Furuno, K
Kira, R
Mihara, F
Hara, T
[J]. BRAIN & DEVELOPMENT, 2006, 28 (01) : 30 - 33
[9] Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey
Seror, Raphaele
Richez, Christophe
Sordet, Christelle
Rist, Stephanie
Gossec, Laure
Direz, Guillaume
Houvenagel, Eric
Berthelot, Jean-Marie
Pagnoux, Christian
Dernis, Emmanuelle
Melac-Ducamp, Sylvie
Bouvard, Beatrice
Asquier, Caroline
Martin, Antoine
Puechal, Xavier
Mariette, Xavier
[J]. RHEUMATOLOGY, 2013, 52 (05) : 868 - 874

← 1 →